Citations

Showing 10 of 108119 citations.

Early change in lactate dehydrogenase is marker of response to PD-1/PDL1 inhibitors.
Shreders, Amanda , Johnson, Douglas B. , Peng, Chengwei , Dronca, Roxana , Kottschade, Lisa A. , Sosman, Jeffrey A. , Joseph, Richard W. , Puzanov, Igor , Bryce, Alan H. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e20045-e20045

10.1200/jco.2015.33.15_suppl.e20045 Get It

Survival trends in young patients with Waldenstrom macroglobulinemia (WM).
Vallumsetla, Nishanth, Ansell, Stephen M. , Kyle, Robert A. , Lacy, Martha Q. , Hayman, Suzanne R. , Kumar, Shaji , Kapoor, Prashant , Paludo, Jonas , Gertz, Morie A. , Go, Ronald S. , Rajkumar, S. Vincent , Buadi, Francis K. , Dispenzieri, Angela , Dingli, David , Leung, Nelson

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8596-8596

10.1200/jco.2015.33.15_suppl.8596 Get It

Phase III trial of stem cell transplantation compared to melphalan and dexamethasone in the treatment of immunoglobulin light chain amyloidosis (AL).
Lacy, Martha Q. , Hayman, Suzanne R. , Kumar, Shaji , Lust, John A., Suman, V., Gertz, Morie A. , Dispenzieri, Angela , Buadi, Francis K. , Dingli, David , Leung, Nelson , Rajkumar, S. Vincent , Hogan, William J.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8595-8595

10.1200/jco.2015.33.15_suppl.8595 Get It

Association of hemophagocytic lymphohistiocytosis (HLH) with poor outcomes in adults with NK- and T-cell lymphoma (NKTCL).
O’Byrne, Megan M., Kapoor, Prashant , Wolanskyj, Alexandra P., Feldman, Andew L., Shah, Meera , Witzig, Thomas E. , Link, Brian K. , Cerhan, James R. , Maurer, Matthew J. , Parikh, Sameer A.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8561-8561

10.1200/jco.2015.33.15_suppl.8561 Get It

FIRST study: Updated overall survival (OS) in stem cell transplant (SCT)-ineligible newly diagnosed multiple myeloma (NDMM) patients (pts) treated with continuous lenalidomide plus low-dose dexamethasone (Rd) vs melphalan, prednisone, and thalidomide (MPT)
Hulin, Cyrille , Belch, Andrew R. , Reece, Donna , Catalano, John, Qiu, Lugui , Schots, Rik , Marek, Jennifer, Chen, Guang , Ervin‐Haynes, Annette, Facon, Thierry T.F. , Dimopoulos, Meletios Α. , Pinto, Antonio , Ludwig, Heinz , Bahlis, Nizar Jacques , Cavo, Michèle , Moreau, Philippe , Qiu, Lugui , LeBlanc, Richard , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 8524-8524

10.1200/jco.2015.33.15_suppl.8524 Get It

Twin randomized studies of daratumumab (DARA; D) plus standard of care (lenalidomide/dexamethasone or bortezomib/dexamethasone [DRd or DVd]) versus Rd or Vd alone in relapsed or refractory multiple myeloma (MM): 54767414MMY3003 (Pollux) and 54767414MMY3004
Palumbo, Antonio , Reece, Donna , Sonneveld, Pieter , Spencer, Andrew , Chanan‐Khan, Asher , Goldschmidt, Hartmut , Yeh, Howard, Schecter, Jordan M. , Qin, Xiang , Amin, Himal, Guckert, Mary, Ahmadi, Tahamtan , Dimopoulos, Meletios Α. , Orlowski, Robert Z.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8609-TPS8609

10.1200/jco.2015.33.15_suppl.tps8609 Get It

A phase I study with an expansion cohort of the combination of ipilimumab and brentuximab vedotin in patients with relapsed/refractory Hodgkin lymphoma: A trial of the ECOG-ACRIN Cancer Research Group (E4412).
Li, Hailun , Fenske, Timothy S. , Ansell, Stephen M. , Diefenbach, Catherine , Kahl, Brad S. , Robertson, Michael J. , Cohen, Jonathan B. , Advani, Ranjana H. , Ambinder, Richard F.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8602-TPS8602

10.1200/jco.2015.33.15_suppl.tps8602 Get It

Randomized, phase III trial of the efficacy and safety of lenalidomide plus R-CHOP vs R-CHOP in patients with untreated ABC-type diffuse large B-cell lymphoma.
Nowakowski, Grzegorz S. , Zhang, Lei , Flament, Jocelyne, Repici, Jacqueline, Chiappella, Annalisa , Witzig, Thomas E. , Spina, Michele , Vitolo, Umberto

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS8600-TPS8600

10.1200/jco.2015.33.15_suppl.tps8600 Get It

Infused autograft lymphocyte to monocyte ratio and survival in T-cell lymphomas post-autologous peripheral blood hematopoietic stem cell transplantation.
Porrata, Luis F. , Inwards, David J. , Ansell, Stephen M. , Micallef, Ivana N. , Johnston, Patrick B. , Hogan, William J. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e19500-e19500

10.1200/jco.2015.33.15_suppl.e19500 Get It

The prognostic impact of combined NPM1+/FLT3- mutational status in newly diagnosed acute myeloid leukemia (AML) patients with intermediate risk cytogenetics according to age and treatment modality.
Patnaik, Mrinal M. , Wolanskyj, Alexandra P., Zblewski, Darci, Elliott, Michelle A. , Litzow, Mark R. , Al‐Kali, Aref , Hefazi, Mehrdad , Siddiqui, Mustaqeem , Alkhateeb, Hassan B. , Hogan, William J.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7064-7064

10.1200/jco.2015.33.15_suppl.7064 Get It